NEA 14 GP, LTD
CIK 1551532 · last filed 2022-01-14
NEA 14 GP, LTD is a corporate insider who has filed 17 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing shows the insider sold $334.6K of IMRA on Jan 14, 2022. Across all open-market trades the lifetime net is +$200.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $22.45B across reported positions. The firm reports its address in Timonium, MD. 70 SEC filings were submitted jointly with NEA Partners 14, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$22.45B
7
17
$200.13M
Filer Profile
SUITE 600
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (IMRA) Delisted | 10%+ Owner | 869,105 | $14.59 | $12.68M | -$912.1K | 2 | 2022-01-14 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 238,381 | $29.08 | $6.93M | $0 | 2 | 2020-09-16 |
| Casper Sleep Inc. (CSPR) Delisted | 10%+ Owner | 6,222,412 | $6.78 | $42.19M | $105.00M | 1 | 2020-02-12 |
| ASND | 10%+ Owner | 82,978,668 | $270.56 | $22.45B | $87.04M | 4 | 2018-09-10 |
| APPN | 10%+ Owner | — | $38.37 | — | $0 | 1 | 2017-05-31 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $9.00M | 1 | 2014-08-06 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-14 | Enliven Therapeutics, Inc. (IMRA) Delisted | Sell (S) | −172,400 | -$334.6K | EDGAR |
| 2022-01-06 | Enliven Therapeutics, Inc. (IMRA) Delisted | Sell (S) | −255,328 | -$577.5K | EDGAR |
| 2020-09-16 | Mersana Therapeutics, Inc. (MRSN) Delisted | Other (J) | −4,000,000 | $0 | EDGAR |
| 2020-04-13 | Mersana Therapeutics, Inc. (MRSN) Delisted | Other (J) | −8,000,000 | $0 | EDGAR |
| 2020-02-12 | Casper Sleep Inc. (CSPR) Delisted | Buy (P) | +8,750,000 | $105.00M | EDGAR |
| 2018-09-10 | ASND | Buy (P) | +9,000,000 | $15.00M | EDGAR |
| 2018-05-09 | — | Mixed | — | $0 | |
| 2018-03-28 | ASND | Buy (P) | +19,713,492 | $37.76M | EDGAR |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M | |
| 2018-03-27 | — | Buy (P) | +2,123,892 | $5.73M |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.